Companies › Alchemia Oncology

Alchemia Oncology

Healthcare 📍 Eight Mile Plains, Australia 👥 1-10 employees 💰 $1.3M raised 📅 Founded 2010

Alchemia Limited is a listed Australian biopharmaceutical company (ASX:ACL) with an FDA approved drug (Fondaparinux sodium) and a late stage oncology product pipeline derived from the HyACT platform. In addition, Alchemia has a drug discovery platform, VAST®, derived from Alchemia’s chemistry expertise.

📊 Company Overview

Sector
Healthcare
Country
Australia
Employees
1-10
Total Raised · Venture
$1.3M
Founded
2010
Cloud
Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider
Workspace🔒 Subscribers only
CDN🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$18K $45K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / Platform🔒 Subscribers only
Frontend Stack🔒 Subscribers only

Detected from Alchemia Oncology's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction